V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004117 | 300002887 | 1.65 | 108 | Curative (C) | 2014-02-20 | 2014-02-20 | CISPLATIN + FLUOROURACIL | N | N | 300018001 | CISPLATIN + FLUOROURACIL |
| 300004118 | 300002888 | 1.48 | 96.9 | Neo-adjuvant (N) | 2016-10-08 | 2016-10-31 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300018002 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004119 | 300002889 | 1.63 | 82.2 | Neo-adjuvant (N) | 2014-03-06 | 2014-04-09 | Cisplatin +Fluorouracil (2 wk) | N | N | 300018003 | CISPLATIN + FLUOROURACIL |
| 300004120 | 300002889 | 1.57 | 57.8 | Palliative (P) | 2014-06-26 | 2014-07-04 | CISPLATIN + FLUOROURACIL | N | N | 300018003 | CISPLATIN + FLUOROURACIL |
| 300004121 | 300002890 | 1.79 | 84 | Curative (C) | 2016-09-16 | 2016-09-16 | Capecitabine | 02 | N | 300018013 | CAPECITABINE |
| 300004122 | 300002891 | null | 98 | Not known (9) | 2014-04-27 | 2014-05-26 | Cetuximab + Radiotherapy Load | N | Y | 300018022 | CETUXIMAB + RT |
| 300004123 | 300002892 | 1.63 | 80 | Curative (C) | 2015-06-16 | 2015-06-22 | CETUXIMAB | N | Y | 300018023 | CETUXIMAB |
| 300004124 | 300002893 | null | null | Adjuvant (A) | 2015-10-18 | 2015-10-20 | Capecitabine | N | N | 300018032 | CAPECITABINE |
| 300004125 | 300002894 | 1.71 | 126 | null | 2015-02-13 | 2015-02-20 | Cetuximab + Radiotherapy Load | N | Y | 300018037 | CETUXIMAB + RT |
| 300004126 | 300002895 | 1.6 | 56 | Neo-adjuvant (N) | 2014-05-23 | 2014-06-03 | Cisplatin + Docetaxel +Fluorouracil | Y | null | 300018043 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004127 | 300002896 | 1.52 | 54.6 | Not known (9) | 2017-05-27 | 2017-06-03 | CETUXIMAB + RT | N | Y | 300018048 | CETUXIMAB + RT |
| 300004128 | 300002897 | 1.81 | null | Curative (C) | 2013-09-19 | 2013-09-26 | CISPLATIN + FLUOROURACIL | 2 | N | 300018278 | CISPLATIN + FLUOROURACIL |
| 300004129 | 300002898 | null | null | Palliative (P) | 2017-07-28 | 2017-08-17 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300018436 | CARBOPLATIN + PACLITAXEL |
| 300004130 | 300002898 | 1.63 | 69 | Palliative (P) | 2013-05-05 | 2013-05-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300018436 | CARBOPLATIN + PACLITAXEL |
| 300004131 | 300002898 | 1.63 | 75.6 | Adjuvant (A) | null | 2013-10-22 | Capecitabine | N | N | 300018436 | CAPECITABINE |
| 300004132 | 300002899 | 1.7 | 43 | Curative (C) | 2015-12-29 | 2015-12-29 | CISPLATIN + FLUOROURACIL | 02 | null | 300018682 | CISPLATIN + FLUOROURACIL |
| 300004133 | 300002900 | 1.53 | 75.2 | Neo-adjuvant (N) | null | 2013-10-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300018695 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004134 | 300002901 | null | 70.8 | Curative (C) | 2014-06-08 | 2014-06-15 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300019098 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004135 | 300002901 | 1.71 | 69 | Curative (C) | 2017-04-24 | 2017-04-24 | CETUXIMAB + RT | Y | Y | 300019098 | CETUXIMAB + RT |
| 300004136 | 300002901 | 1.81 | 60 | Curative (C) | 2017-07-05 | 2017-07-14 | Cetuximab + Radiotherapy Load | Y | Y | 300019098 | CETUXIMAB + RT |
| 300004137 | 300007971 | 1.77 | 89.7 | Neo-adjuvant (N) | 2017-11-28 | 2017-11-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300020073 | CISPLATIN + FLUOROURACIL |
| 300004138 | 300002902 | 1.65 | 67 | null | 2017-12-09 | 2017-12-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300020319 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004139 | 300002902 | 1.74 | 67.5 | Adjuvant (A) | 2014-05-02 | 2014-05-02 | Capecitabine | 02 | N | 300020319 | CAPECITABINE |
| 300004140 | 300002902 | 1.58 | 94 | Palliative (P) | 2013-09-22 | 2013-10-03 | CISPLATIN + FLUOROURACIL | 02 | null | 300020319 | CISPLATIN + FLUOROURACIL |
| 300004141 | 300002903 | 1.63 | 67.3 | Neo-adjuvant (N) | 2017-03-19 | 2017-03-20 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300020937 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004142 | 300002904 | 1.69 | 59 | Curative (C) | 2015-02-25 | 2015-03-20 | CETUXIMAB | N | Y | 300020990 | CETUXIMAB |
| 300004143 | 300002905 | 1.67 | 55.5 | Neo-adjuvant (N) | 2013-09-05 | 2013-09-06 | CISPLATIN + FLUOROURACIL | 02 | N | 300021037 | CISPLATIN + FLUOROURACIL |
| 300004144 | 300002906 | 1.68 | 102 | Curative (C) | 2013-06-11 | 2013-07-01 | Cetuximab + Radiotherapy Load | N | N | 300021064 | CETUXIMAB + RT |
| 300004145 | 300002906 | 1.73 | 64.5 | Not known (9) | null | 2013-08-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300021064 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004146 | 300002907 | 1.6 | 99 | Adjuvant (A) | 2016-08-18 | 2016-08-30 | Capecitabine | N | N | 300022092 | CAPECITABINE |
| 300004147 | 300002908 | null | 49.1 | Palliative (P) | 2015-07-31 | 2015-08-30 | Capecitabine | 02 | N | 300022237 | CAPECITABINE |
| 300004148 | 300002909 | 1.68 | 52.3 | Neo-adjuvant (N) | 2015-01-03 | 2015-01-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300022240 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004149 | 300002910 | 1.71 | 84.6 | null | 2017-06-03 | 2017-06-04 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 300022247 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004150 | 300002911 | 1.72 | 94 | Palliative (P) | 2016-10-14 | 2016-10-14 | Capecitabine | 2 | null | 300022254 | CAPECITABINE |
| 300004152 | 300002913 | 1.67 | 46 | null | 2015-02-05 | 2015-02-27 | CETUXIMAB | N | N | 300022258 | CETUXIMAB |
| 300004153 | 300002914 | null | 86.4 | null | 2015-06-24 | 2015-07-16 | CISPLATIN + FLUOROURACIL | N | N | 300022259 | CISPLATIN + FLUOROURACIL |
| 300004154 | 300002915 | 1.84 | 81.1 | Disease modification (D) | 2017-05-14 | 2017-06-14 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 300022267 | CARBOPLATIN + PACLITAXEL |
| 300004155 | 300002916 | 1.7 | 52 | Curative (C) | 2017-03-18 | 2017-03-22 | Cetuximab 7 day (Cycle 1) | 02 | null | 300022276 | CETUXIMAB |
| 300004156 | 300002917 | 1.52 | 56 | Adjuvant (A) | null | 2016-04-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 300022287 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004158 | 300002919 | null | null | Curative (C) | 2016-09-30 | 2016-09-30 | CETUXIMAB | 2 | N | 300022298 | CETUXIMAB |
| 300004159 | 300002919 | 1.59 | 77.2 | Curative (C) | 2014-06-09 | 2014-08-13 | CETUXIMAB | N | N | 300022298 | CETUXIMAB |
| 300004160 | 300002920 | 1.76 | 81.2 | 2 | 2017-08-07 | 2017-11-24 | Cisplatin +Fluorouracil (3 wk) | N | N | 300022305 | CISPLATIN + FLUOROURACIL |
| 300004161 | 300002920 | 1.59 | 77.5 | Curative (C) | 2016-10-18 | 2016-11-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300022305 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004163 | 300002922 | 1.84 | 77 | Adjuvant (A) | 2016-03-02 | 2016-03-02 | Capecitabine | N | N | 300022313 | CAPECITABINE |
| 300004167 | 300002924 | 1.63 | 104.4 | Curative (C) | 2017-08-08 | 2017-08-20 | CISPLATIN + FLUOROURACIL | 02 | null | 300022333 | CISPLATIN + FLUOROURACIL |
| 300004168 | 300006074 | 1.57 | 60.5 | Neo-adjuvant (N) | null | 2016-03-24 | Cisplatin +Fluorouracil (2 wk) | N | N | 300022340 | CISPLATIN + FLUOROURACIL |
| 300004169 | 300007440 | 1.6 | 77 | Curative (C) | 2015-03-19 | 2015-04-03 | Cetuximab + Radiotherapy Load | N | Y | 300022345 | CETUXIMAB + RT |
| 300004170 | 300002925 | 1.58 | 87 | Palliative (P) | 2013-11-17 | 2013-12-03 | Capecitabine | N | N | 300022351 | CAPECITABINE |
| 300004171 | 300002926 | null | 77.3 | Curative (C) | 2016-03-03 | 2016-03-04 | CETUXIMAB + RT | N | Y | 300022357 | CETUXIMAB + RT |
| 300004172 | 300002927 | 1.63 | 63.8 | Neo-adjuvant (N) | 2015-01-09 | 2015-01-19 | Cisplatin +Fluorouracil (3 wk) | Y | N | 300022363 | CISPLATIN + FLUOROURACIL |